Cite
HARVARD Citation
Hodi, F. et al. (n.d.). Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC). Journal for immunotherapy of cancer. p. . [Online].